Brief Article Open Access
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Mar 21, 2013; 19(11): 1770-1777
Published online Mar 21, 2013. doi: 10.3748/wjg.v19.i11.1770
Psychosocial factors and their association with reflux oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma
Paul Denver, Michael Donnelly, Liam J Murray, Lesley A Anderson, Centre for Public Health, Queen’s University Belfast, Belfast BT12 6BJ, Northern Ireland, United Kingdom
Author contributions: Murray LJ was the PI of the FINBAR study; Anderson LA was the project co-ordinator for the FINBAR Study; Donnelly M conceptualised and designed the sub-study of psychological factors including their assessment and supported by Donnelly M; Anderson LA supervised the analysis and write-up of results undertaken by Denver P. All authors contributed to the writing and production of the manuscript.
Correspondence to: Lesley A Anderson, PhD, Lecturer in Epidemiology, Centre for Public Health, Queen’s University Belfast, Institute of Clinical Sciences, Block B, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, United Kingdom. l.anderson@qub.ac.uk
Telephone: +44-28-90632315 Fax: +44-28-90248017
Received: September 18, 2012
Revised: October 25, 2012
Accepted: November 14, 2012
Published online: March 21, 2013

Abstract

AIM: To investigate the role of psychological characteristics as risk factors for oesophageal adenocarcinoma (OAC), as well as the reflux-mediated precursor pathway.

METHODS: An all-Ireland population-based case-control study recruited 230 reflux oesophagitis (RO), 224 Barrett’s oesophagus (BO) and 227 OAC patients and 260 controls. Each case/control group completed measures of stress, depression, self-efficacy, self-esteem, repression and social support. A comparative analysis was undertaken using polytomous logistic regression adjusted for potential confounders.

RESULTS: Compared to controls, OAC patients were almost half as likely to report high stress levels over their lifetime (P = 0.010, OR 0.51; 95%CI: 0.29-0.90) and 36% less likely to report having experienced depression (OR 0.64; 95%CI: 0.42-0.98). RO patients reported significantly higher stress than controls particularly during middle- and senior-years (P for trends < 0.001). RO patients were 37% less likely to report having been highly emotionally repressed (OR 0.63; 95%CI: 0.41-0.95). All case groups (OAC, RO and BO) were more likely than controls to report having had substantial amounts of social support (OR 2.84; 95%CI: 1.63-4.97; OR 1.97; 95%CI: 1.13-3.44 and OR 1.83; 95%CI: 1.03-3.24, respectively).

CONCLUSION: The improved psychological profile of OAC patients may be explained by response shift. The role of psychological factors in the development of OAC requires further investigation.

Key Words: Reflux oesophagitis, Barrett’s oesophagus, Oesophageal adenocarcinoma, Adjustment, Psychological, Psychosocial factors



INTRODUCTION

Gastro-oesophageal reflux comprises a series of chronic symptoms caused by abnormal reflux of gastric and intestinal digestive juice[1] which may cause inflammation of the oesophageal mucosa reflux oesophagitis (RO)[2] or cause a squamous to columnar cell metaplasia within the distal oesophagus Barrett’s oesophagus (BO)[3]. Prevalence rates for gastro-oesophageal reflux disease in western countries range from 10%-20%[4,5]. Incidence of BO in Northern Ireland is 567/100  000 of the population (unpublished data, Northern Ireland BO Registry). Although the absolute risk remains low (0.5% per patient per year)[6], BO confers an increased risk of developing oesophageal adenocarcinoma (OAC)[7], the incidence of which has increased by 600% in western countries in recent decades[8]. The incidence rate for oesophageal cancer in Northern Ireland is similar to rates reported elsewhere[9].

Previous studies have found associations between hypothesized risk factors including diet, obesity and smoking[10-14] and the development of OAC though the demographic distribution of risk factors does not fully align with OAC incidence[15]. Stress appears to affect the neuroendocrine and immune systems as well as the sympathetic nervous system[16,17]. In population-based studies, job strain-related stress has been positively associated with symptomatic reflux and an increased risk of OAC[17-19]. However, the role of psychosocial factors in the development of OAC and it’s precursor lesions has not been investigated.

Data from an all-Ireland population-based, case-control study (the FINBAR Study) was used to investigate the nature and extent to which different psychosocial factors (e.g., stress and depressed mood) affected the development of OAC, including the influence such factors may have on the reflux-mediated precursor pathway.

MATERIALS AND METHODS

The FINBAR study was an all-Ireland population-based case-control study comprising three patient groups with (1) OAC; (2) long-segment BO; and (3) RO and a group of normal population controls. All participants were Caucasian and aged between 35-85 years. The design of the FINBAR Study has been described elsewhere[10,20]. Briefly, OAC cases had histological confirmation of adenocarcinoma within the oesophagus. They were identified using electronic pathology records from all pathology laboratories in Northern Ireland and from the main hospitals involved in the treatment of oesophageal cancer in the Republic of Ireland. BO patients had histological confirmation of specialized intestinal metaplasia within the oesophagus and at least 3 centimeters of BO observed at endoscopy. RO patients were those diagnosed with macroscopically visible erosive oesophagitis (grades 2-4 in the Savary Miller/Hetzel-Dent classification or grades B, C or D in the Los Angeles classification) at upper gastrointestinal (GI) endoscopy. BO and RO patients were frequency matched (within 5-year age- and sex-strata) to the distribution of OAC patients. Control subjects had no history of oesophageal or other GI cancer or BO. They were frequency matched by sex, and 5-year age bands to OAC patients.

For the psychosocial assessment patients were asked to reflect on their life as a whole when answering the questions. Self-perceived stress or daily strain was assessed using the 4-item Reed Stress Inventory. Responses to items were scored as follows: 0, no response on one or more statements; 1, “not at all” for all four statements; 2, “not at all” for any three statements with any other response for the fourth; 3, “not at all” for any two statements with “hardly true” for the other two; 4, “not at all” for any one or two statements with any other responses for the remainder but not those for a score of 3; 5, all other response sets not specified under 0, 1, 2, 3, 4, 6, 7 or 8; 6, “moderately true” to all four statements, or “moderately true” for three statements with “exactly true” for the fourth; 7, “exactly true” for any three statements with “moderately true” or “hardly true” for the fourth; and 8, “exactly true” in response to all four statements. Scores from 1 to 8 were categorised as representing high (6-8), medium (4-5), or low (1-3) levels of stress.

A 4-part item was used to assess self-reported stress across the lifespan from: (1) childhood/teenager (up to 19 years); (2) young adulthood (20-39 years); (3) midlife (40-59 years); and (4) senior or later years in life (60-85 years). Each life period was considered a separate variable in the analyses in order to gauge approximately the extent to which any particular developmental period in an individual’s life had been stressful and to assess its significance for patients compared to controls.

Depressed mood was assessed using an adapted 2-item case-finding instrument[21]. A score of 1-2 on either question indicated a “not depressed” status while a score of 3-4 on either question indicated that the respondent was likely to be “depressed” or to have a depressed mood.

Self-efficacy and coping ability were measured using a 10-item scale designed to assess the extent to which a respondent had a self-belief that they had the capacity to overcome difficult tasks and cope with adversity. Responses on the 4-point likert scale were summed yielding a score of between 10 and 40 in the direction of increasing self-efficacy and coping ability. Self-efficacy was categorized as low (scores of 10-29), medium (30-34) and high (35-40) based on the tertile distribution of scores among the controls.

A single-item was used to measure self-esteem with a score of 1-2 indicating low self-esteem and a score of 3-4 indicating high self-esteem.

A single-item was used to assess emotional repression. A high score (3-4) indicated a tendency to share feelings and emotions relatively easily and a low score (1-2) was endorsed by respondents who were reticent or repressive in nature.

The responses to three questions on social support and loneliness were summed and categorized as indicating varying degrees of support from hardly any (scores 0-8), some (score 9), moderate (score 10) and substantial (scores 11-12) based on the quartile distribution of scores among the control group.

Ethical approval

Ethical approval for the FINBAR study was obtained from the Research Ethics Committee of the Queen’s University Belfast, the Clinical Research Ethics Committee of the Cork Teaching Hospitals and the Research Ethics Committee Board of St. James’s Hospital, Dublin.

Statistical analysis

Group t-tests and Pearson χ2 tests were used to compare cases and controls. Polytomous multivariate logistic regression was used to compare the psychosocial factors in each case group with the control group, adjusting for potential confounders including gender, age, years of full-time education, job type (manual, non-manual), Gastroesophageal reflux (GOR) symptoms (never, ever), smoking status (never, ex-smoker, current smoker), alcohol consumption (g/d) and BMI (self-reported weight 5-years before interview divided by height measured at interview).

RESULTS

In total, 227 OAC patients, 224 BO patients, 230 RO patients and 260 controls were recruited into the study with participation rates of 64%, 82%, 69% and 42% respectively. Case groups and controls were similar regarding gender and age due to frequency matching. Other characteristics are displayed in Table 1.

Table 1 Characteristics of participants.
VariablesControlsROBOOAC
n (%)n (%)P valuen (%)P valuen (%)P value
Gender0.470.550.99
Male220 (84.6)189 (82.2)185 (82.6)192 (84.6)
Female40 (15.4)41 (17.8)39 (17.4)35 (15.4)
Age (yr)63.061.70.2262.40.5764.20.28
Education (yr)12.010.8< 0.00111.30.0110.7< 0.001
Job type0.710.020.01
Manua119 (48.0)107 (48.2)130 (59.1)128 (59.5)
Non-manual129 (52.0)115 (51.8)90 (40.9)87 (40.5)
GOR symptoms< 0.001< 0.001< 0.001
Neve211 (81.2)140 (60.9)60 (26.8)117 (51.5)
Ever49 (18.8)90 (39.1)164 (73.2)110 (48.5)
Smoking status0.030.40< 0.001
Never102 (40.2)109 (48.4)87 (39.2)45 (20.4)
Ex-smoker107 (42.1)68 (30.2)85 (38.3)99 (44.8)
Current45 (17.7)48 (21.3)50 (22.5)77 (34.8)
Alcohol (g/d)26.122.00.1522.30.2119.20.01
Body mass index (kg/m2)27.027.80.0527.00.9028.7< 0.001
Reed stress inventory, mean ± SD0.0140.187< 0.001
Mean score (range 2-8)4.50 ± 2.084.11 ± 1.884.28 ± 2.083.80 ± 2.09
Stress teenage years0.1460.5390.655
Mean score (range 1-51.80 ± 1.051.67 ± 0.951.86 ± 1.181.85 ± 1.17
Stress young adulthood0.3010.3280.486
Mean score (range 1-52.45 ± 1.232.67 ± 1.112.34 ± 1.252.37 ± 1.24
Stress midlife< 0.0010.0380.928
Mean score (range 1-5)2.49 ± 1.263.33 ± 1.202.75 ± 1.342.50 ± 1.33
Stress senior years< 0.0010.080.088
Mean score (range 1-5)2.07 ± 1.172.80 ± 1.422.34 ± 1.352.33 ± 1.37
Depression0.1070.1470.109
Mean score (range 2-8)4.11 ± 1.744.42 ± 2.374.38 ± 2.253.82 ± 2.31
Self efficacy< 0.0010.794< 0.001
Mean score (range 10-40)32.0 ± 4.7633.8 ± 4.3231.8 ± 5.5234.3 ± 4.89
Self esteem0.8280.0220.034
Mean score (range 1-4)2.95 ± 0.812.93 ± 1.102.76 ± 1.043.13 ± 0.97
Repression0.0970.5010.554
Mean score2.80 ± 0.892.64 ± 1.172.86 ± 1.052.86 ± 1.17
Social support< 0.0010.40< 0.001
Mean score (range 1-4)3.57 ± 0.603.82 ± 0.503.62 ± 0.633.76 ± 0.48

There were no significant trends between reported stress levels as measured by the Reed Stress Inventory and risk of RO or BO (Table 2). However, OAC patients were half as likely to report high stress than controls (OR 0.51; 95%CI: 0.29-0.90). Stress levels were similar during childhood/teenage years for RO, BO, OAC cases and controls, respectively. Regarding young adulthood, there was a significant trend between having RO and reported stress; RO cases also reported significantly much higher stress during middle- and senior-years than controls (almost 10-fold and 6-fold more, respectively) with a significant linear trend (P for trend < 0.001) observed for each point on the life-span stress scale.

Table 2 Self-reported stress levels during lifetime.
ControlsRO
BO
OAC
Stress levelsn (%)n (%)AOR (95%CI)n (%)AOR (95%CI)n (%)AOR (95%CI)
Reed stress inventory levels
Low45 (17.6)63 (27.9)1.0060 (27.2)1.0081 (36.3)1.00
Medium154 (60.2)122 (54.0)0.92 (0.51-1.63)102 (46.2)0.51 (0.31-0.86)91 (40.8)0.37 (0.23-0.61)
High57 (22.3)41 (18.1)1.43 (0.64-3.22)59 (26.7)0.60 (0.33-1.09)51 (22.9)0.51 (0.29-0.90)
P for trend 0.48P for trend 0.10P for trend 0.010
Teenage years
1135 (52.7)132 (58.7)1.00122 (55.5)1.00127 (57.5)1.00
267 (26.1)53 (23.6)1.05 (0.64-1.71)42 (19.1)0.73 (0.43-1.23)32 (14.5)0.63 (0.37-1.06)
331 (14.1)26 (11.6)0.77 (0.40-1.49)31 (14.1)1.06 (0.57-1.96)42 (19.0)1.50 (0.84-2.67)
416 (6.3)11 (4.9)0.67 (0.26-1.70)14 (6.4)0.75 (0.31-1.79)9 (4.1)0.58 (0.23-1.48)
57 (2.7)3 (1.3)0.28 (0.06-1.26)11 (5.0)0.76 (0.25-2.29)11 (5.0)1.18 (0.40-3.48)
P for trend 0.10P for trend 0.55P for trend 0.85
Young adulthood
164 (25.0)38 (16.9)1.0076 (34.7)1.0070 (32.3)1.00
267 (26.2)61 (27.1)2.04 (1.11-3.76)47 (21.5)0.59 (0.34-1.04)52 (24.0)0.80 (0.47-1.38)
382 (32.0)75 (33.3)1.92 (1.06-3.49)57 (26.0)0.47 (0.27-0.81)55 (25.4)0.67 (0.39-1.14)
432 (12.5)39 (17.3)2.65 (1.27-5.55)23 (10.5)0.46 (0.22-0.96)24 (11.1)0.71 (0.35-1.44)
511 (4.3)12 (5.3)3.20 (1.07-9.55)16 (7.3)0.86 (0.33-2.28)16 (7.4)1.22 (0.47-3.18)
P for trend 0.01P for trend 0.05P for trend 0.49
Midlife
168 (28.7)20 (9.1)1.0052 (25.0)1.0058 (27.9)1.00
257 (24.1)38 (17.2)2.56 (1.22-5.37)39 (18.8)0.87 (0.48-1.59)62 (29.8)1.25 (0.73-2.16)
355 (23.2)50 (22.6)4.04 (1.97-8.25)48 (23.1)1.07 (0.59-1.94)38 (18.3)0.95 (0.53-1.71)
441 (17.3)76 (34.4)8.50 (4.14-17.46)47 (22.6)1.23 (0.65-2.30)25 (12.0)0.70 (0.36-1.36)
516 (6.8)37 (16.7)9.82 (4.11-23.45)22 (10.6)1.27 (0.55-2.89)25 (12.0)1.60 (0.72-3.53)
P for trend 0.001P for trend 0.33P for trend 0.97
Senior years
164 (42.4)30 (24.4)1.0047 (39.2)1.0047 (37.3)1.00
238 (25.1)28 (22.8)1.76 (0.86-3.61)23 (19.2)0.71 (0.35-1.45)32 (25.4)1.08 (0.56-2.09)
330 (19.9)22 (17.9)1.77 (0.82-3.83)22 (18.3)0.93 (0.44-1.96)19 (15.1)0.84 (0.40-1.78)
412 (8.0)23 (18.7)4.28 (1.72-10.67)18 (15.0)2.15 (0.85-5.43)14 (11.1)1.71 (0.67-4.35)
57 (4.6)20 (16.3)5.92 (1.72-16.77)10 (8.3)1.48 (0.48-4.54)14 (11.1)2.35 (0.82-6.70)
P for trend 0.001P for trend 0.20P for trend 0.14

OAC cases were 36% less likely than controls to report depression; no significant association was observed between depression and BO or RO (Table 3). Self-efficacy levels were 3-times higher in RO patients and 2-times higher in OAC patients compared to controls. No significant association was observed for self-efficacy and BO. OAC patients were 58% more likely than controls to report high self-esteem though the association was not statistically significant (95%CI: 0.99-2.52). Self-esteem did not differ significantly between RO or BO cases respectively and controls. RO patients were 37% less likely than controls to report being repressed; significant associations were not observed between repression and BO or OAC status. RO, BO and OAC patients were more likely to report high levels of social support than controls.

Table 3 Psychosocial factors by group status.
ControlsRO
BO
OAC
n (%)n (%)AOR (95%CI)n (%)AOR (95%CI)n (%)AOR (95%CI)
Depression
No163 (63.7)131 (58.0)1.00118 (52.2)1.00147 (65.9)1.00
Yes93 (36.3)95 (42.0)0.92 (0.61-1.40)104 (46.9)1.12 (0.74-1.70)76 (34.1)0.64 (0.42-0.98)
Self-efficacy
Low84351.00791.00431.00
Medium74551.65 (0.92-2.98)540.61 (0.36-1.05)491.06 (0.60 -1.87)
High971353.14 (1.86-5.31)860.78 (0.48-1.27)1282.17 (1.32- 3.57)
Self-esteem
Low67 (26.2)63 (27.9)1.0077 (35.0)1.0046 (20.6)1.00
High189 (73.4)163 (72.1)0.93 (0.59 - 1.47)143 (65.0)0.76 (0.48 -1.18)177 (79.4)1.58 (0.99 - 2.52)
Repression
Low83 (32.4)100 (44.4)1.0071 (32.0)1.0072 (32.3)1.00
High173 (67.6)125 (55.6)0.63 (0.41-0.95)151 (68.0)1.20 (0.78 -1.86)151 (67.7)1.10 (0.72-1.67)
Social support
Hardly any89781.00771.00601.00
Some89530.72 (0.43-1.21)611.12 (0.67-1.86)581.28 (0.77-2.14)
Moderate37300.93 (0.49-1.77)301.26 (0.66-2.39)381.89 (1.02-3.48)
Substantial41641.97 (1.13-3.44)541.83 (1.03-3.24)672.84 (1.63-4.97)
DISCUSSION

This is the first study to investigate psychological characteristics of RO, BO and OAC patients as possible risk factors for the development of these conditions. OAC patients compared to controls reported significantly lower stress levels throughout their life in contrast to comparisons between RO and BO patients and controls. RO patients reported significantly higher stress levels in later life. OAC patients were also less likely than controls to report depression and to have higher (albeit non-significant) self-esteem and significantly better coping skills. All three case groups reported more social support than controls.

It has been hypothesized that psychosocial factors such as stress and social support may mediate or moderate cancer risk through, for example, influencing neuroendocrine and immune functioning[22]. Long-term exposure to stress causes persistent activation of the hypothalamic-pituitary-adrenal axis reducing tumour suppressor capability and suppressing DNA repair functions[23-26] through suppression of lymphocyte activity[27] and cytotoxic T-cell and natural killer cell activity[28,29]. However, perceived stress over one’s lifetime appeared to be significantly lower in OAC patients. Other factors such as recall bias and response shift may explain these reported lower levels of stress. Retrospective reporting may be skewed by recall bias as patients may lose their memory trace with time and their salience following a cancer diagnosis. Also, the current study identified an overall positive psychological profile among OAC patients including less depression, higher self-efficacy, higher self-esteem and more social support. The phenomenon of “response shift” may help to explain the findings in so far as a perceptual adjustment may occur in how a patient views stress or adversity and friends; and family tend to be sympathetic, caring and more likely to offer support at times of illness[30-32]. Furthermore, a “cancer experience” has the potential to effect positive psychological change or post-traumatic growth (PTG)[33]. For example, studies have found that PTG is inversely associated with emotional distress[34] and positively associated with happiness[35]. The majority of studies that have investigated the role of PTG have been conducted with patients with breast cancer, a form of cancer which has relatively high survival rates. In Europe, five and ten year survival rates of women diagnosed with breast cancer between 2000 and 2002 were 82% and 72%, respectively[35]. In contrast, survival rates for OAC patients are much lower between 13% and 17% for males and females, respectively, in Ireland[36]. A diagnosis of a cancer such as OAC with a poor prognosis and survival rate might be expected to result in despair, pessimism, reduce active coping and increase dependence on more an emotional-based style; and, in turn, these factors might be expected to reduce potential for PTG. In addition, OAC presents a unique symptom complex and the psychosocial issues and disabilities that arise from the treatment modalities involved with this cancer might be expected to influence a patient’s benefit finding ability and diminish their capacity for PTG. However, this study - the first to investigate PTG and response shift in OAC patients - suggests that benefit finding and positive well-being may be experienced by OAC patients despite the often hopeless prognosis. High levels of self-efficacy reported by OAC patients may serve to regulate the stress process, relieve depression and improve cancer symptoms[37,38]. For example, OAC patients were less depressed than controls (OR 0.64; 95%CI: 0.42-0.98).

Perceived stress was higher in RO patients (particularly among older patients) in line with other studies [that demonstrate a link between psychosocial factors and gastro-oesophageal reflux disease (GORD)[19,39]] even though RO patients were more likely than controls to report high self-efficacy. The association between GORD and somatisation disorder and depression reported elsewhere[40] was not supported by the results of this study. The voluntary self-selection to participate in the study may have led to a form of ascertainment bias, whereby individuals with lower self-efficacy may have been less likely to participate in the study. Also, recall bias may have over-reported prior levels of self-efficacy, based on their current ability to cope with adversity.

Repression has been linked with poor health and cancer[41-45]. However, there was no significant association found between repression and OAC. The single-item measure of repression used in this study may not have been sufficiently sensitive[46]. RO patients were less likely than controls to report high repression. This relationship may have been moderated by social support - RO patients were more likely than controls to report that they had good social support.

This is a large, all-Ireland, population-based study, for which there was a relatively high response rate among case groups. The low control group response rate (42%), however, merits a cautious approach to the interpretation of results (e.g., representativeness of the population) though adjusted analyses were performed on potential confounders such as GOR, gender, age at interview, smoking status, alcohol consumption, occupation and BMI.

The retrospective nature of this study meant that it was susceptible to recall bias; this problem may be overcome by using a prospective study design. The resource-heavy nature, however, of these kinds of studies means that a retrospective study design, which can generate large data sets relatively quickly and efficiently, is usually more practicable. In any case, the incidence of OAC is still relatively low[8] and the sample population is not large enough for a prospective study.

In conclusion, our results suggest that there may be a complex interaction between psychological factors regarding the development of RO, BO and OAC. Furthermore, the results presented here indicate that these conditions have significant psychological health consequences. Further research with enhanced methodological rigor is required to clarify the role of psychological factors in the development of OAC.

ACKNOWLEDGMENTS

We appreciate the contributions made by the study participants and their families. We would like to thank the clinicians who were contacted throughout the study period and their secretaries for administrative support. We acknowledge the contribution of Miss Siobhan Reynolds, Ms Majella Gallagher, Ms Carol Anderson and Mr. Martin McAnaespie and Dr. Damian McManus. Thanks to the Northern Ireland Cancer Registry and National Cancer Registry Ireland for their support and involvement in the research. The FINBAR study group members include Johnston BT, Watson RGP, McGuigan J, Ferguson HR (Belfast Health and Social Care Trust, Belfast, County Antrim, United Kingdom), Murphy SJ (Craigavon Hospital, Northern Ireland), JV Reynolds (St James” Hospital, Dublin, Ireland) and H Comber (National Cancer Registry of Ireland, Cork, Ireland).

COMMENTS
Background

Incidence of oesophageal adenocarcinoma (OAC) is rising more rapidly than that of any other form of cancer in the western world. The causes of OAC are largely unknown. Psychological factors are thought to mediate cancer risk for other forms of malignancies, but have not been investigated with regards to OAC or the conditions predisposing to it, including reflux oesophagitis (RO) and Barrett’s oesophagus (BO).

Research frontiers

Several risk factors for OAC have been investigated, including diet, obesity and smoking. These factors mediate cancer risk in a variety of ways and have been shown to confer an increased risk of OAC. These risk factors, however don”t fully explain the dramatic increase that has been seen over the last three decades (600% in Western countries) and psychosocial factors are thought to play a role.

Innovations and breakthroughs

Stress has been shown to mediate immune function, and subsequently cancer risk in several forms of cancer, through the hypothalamic-pituitary-adrenal axis. Other psychosocial risk factors for cancer, such as depression, anxiety and job strain have also been investigated, but it remains unclear to what extent these factors are influencing the risk of OAC; either independently or through RO or BO.

Applications

Survival rates for OAC patients are relatively low and the comorbidities and treatment regimens for this form of cancer can greatly diminish quality of life in these patients. Identification of unambiguous risk factors for both OAC itself as well as the premalignant, reflux-mediated pathway, would provide the potential for early intervention and greatly improve survival and quality of life for RO, BO and OAC patients.

Terminology

Oesophageal adenocarcinoma is a cancer of the oesophagus that originates in the glandular tissue of the epithelium. Barrett’s oesophagus is a squamous to columnar cell metaplasia within the distal oesophagus and is the main risk factor for OAC. Reflux oesophagitis is an inflammation of the oesophageal mucosa and is caused by abnormal gastro-oesophageal reflux; it also increases the risk of developing OAC.

Peer review

This is a very well written original manuscript assessing relationship between psychosocial factors and reflux esophagitis, Barrett’s esophagus and esophageal adenocarcinoma.

Footnotes

P- Reviewer Blonski W S- Editor Huang XZ L- Editor A E- Editor Zhang DN

References
1.  Herbella FA, Patti MG. Gastroesophageal reflux disease: From pathophysiology to treatment. World J Gastroenterol. 2010;16:3745-3749.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 60]  [Cited by in F6Publishing: 61]  [Article Influence: 4.4]  [Reference Citation Analysis (3)]
2.  Della Casa D, Missale G, Cestari R. [GerdQ: tool for the diagnosis and management of gastroesophageal reflux disease in primary care]. Recenti Prog Med. 2010;101:115-117.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Zou D, He J, Ma X, Chen J, Gong Y, Man X, Gao L, Wang R, Zhao Y, Yan X. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroenterol. 2011;46:133-141.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 60]  [Article Influence: 4.6]  [Reference Citation Analysis (0)]
4.  Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17:14-27.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 149]  [Cited by in F6Publishing: 164]  [Article Influence: 12.6]  [Reference Citation Analysis (0)]
5.  Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet. 2009;373:850-861.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 234]  [Cited by in F6Publishing: 225]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
6.  Lippmann QK, Crockett SD, Dellon ES, Shaheen NJ. Quality of life in GERD and Barrett’s esophagus is related to gender and manifestation of disease. Am J Gastroenterol. 2009;104:2695-2703.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 35]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
7.  Ong CA, Lao-Sirieix P, Fitzgerald RC. Biomarkers in Barrett’s esophagus and esophageal adenocarcinoma: predictors of progression and prognosis. World J Gastroenterol. 2010;16:5669-5681.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 48]  [Cited by in F6Publishing: 41]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
8.  Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-146.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 956]  [Cited by in F6Publishing: 1038]  [Article Influence: 54.6]  [Reference Citation Analysis (0)]
9.  Murphy SJ, Dickey W, Hughes D, O’Connor FA. Surveillance for Barrett’s oesophagus: results from a programme in Northern Ireland. Eur J Gastroenterol Hepatol. 2005;17:1029-1035.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 10]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
10.  Anderson LA, Watson RG, Murphy SJ, Johnston BT, Comber H, Mc Guigan J, Reynolds JV, Murray LJ. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585-1594.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Murphy SJ, Anderson LA, Ferguson HR, Johnston BT, Watson PR, McGuigan J, Comber H, Reynolds JV, Murray LJ, Cantwell MM. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett’s esophagus. J Nutr. 2010;140:1757-1763.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 50]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
12.  Cross AJ, Freedman ND, Ren J, Ward MH, Hollenbeck AR, Schatzkin A, Sinha R, Abnet CC. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol. 2011;106:432-442.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 118]  [Cited by in F6Publishing: 127]  [Article Influence: 9.8]  [Reference Citation Analysis (0)]
13.  Nam SY, Choi IJ, Nam BH, Park KW, Kim CG. Obesity and weight gain as risk factors for erosive oesophagitis in men. Aliment Pharmacol Ther. 2009;29:1042-1052.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 24]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
14.  Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010;102:1344-1353.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 204]  [Cited by in F6Publishing: 208]  [Article Influence: 14.9]  [Reference Citation Analysis (0)]
15.  Kubo A, Corley DA, Jensen CD, Kaur R. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett’s oesophagus. Nutr Res Rev. 2010;23:230-246.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 75]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
16.  Graeff FG. [Anxiety, panic and the hypothalamic-pituitary-adrenal axis]. Rev Bras Psiquiatr. 2007;29 Suppl 1:S3-S6.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2009;21:149-159.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 176]  [Cited by in F6Publishing: 179]  [Article Influence: 11.9]  [Reference Citation Analysis (0)]
18.  Jansson C, Jeding K, Lagergren J. Job strain and risk of esophageal and cardia cancers. Cancer Epidemiol. 2009;33:473-475.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 16]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
19.  Jansson C, Wallander MA, Johansson S, Johnsen R, Hveem K. Stressful psychosocial factors and symptoms of gastroesophageal reflux disease: a population-based study in Norway. Scand J Gastroenterol. 2010;45:21-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 34]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
20.  Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, Bamford KB, Ghazy A, McCarron P, McGuigan J, Reynolds JV. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut. 2008;57:734-739.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 113]  [Cited by in F6Publishing: 121]  [Article Influence: 7.6]  [Reference Citation Analysis (0)]
21.  Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12:439-445.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1218]  [Cited by in F6Publishing: 1104]  [Article Influence: 40.9]  [Reference Citation Analysis (0)]
22.  Michael YL, Carlson NE, Chlebowski RT, Aickin M, Weihs KL, Ockene JK, Bowen DJ, Ritenbaugh C. Influence of stressors on breast cancer incidence in the Women’s Health Initiative. Health Psychol. 2009;28:137-146.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 68]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
23.  McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 2000;886:172-189.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1152]  [Cited by in F6Publishing: 1113]  [Article Influence: 46.4]  [Reference Citation Analysis (0)]
24.  Cohen L, Marshall GD, Cheng L, Agarwal SK, Wei Q. DNA repair capacity in healthy medical students during and after exam stress. J Behav Med. 2000;23:531-544.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Kiecolt-Glaser JK, Robles TF, Heffner KL, Loving TJ, Glaser R. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann Oncol. 2002;13 Suppl 4:165-169.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 80]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
26.  Nielsen NR, Kristensen TS, Strandberg-Larsen K, Zhang ZF, Schnohr P, Grønbaek M. Perceived stress and risk of colorectal cancer in men and women: a prospective cohort study. J Intern Med. 2008;263:192-202.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 11]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
27.  Li H, Chen L, Zhang Y, Lesage G, Zhang Y, Wu Y, Hanley G, Sun S, Yin D. Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a β-arrestin 2 dependent manner. J Neuroimmunol. 2011;233:73-79.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 16]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
28.  Ben-Eliyahu S, Shakhar G, Page GG, Stefanski V, Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation. 2000;8:154-164.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 166]  [Cited by in F6Publishing: 160]  [Article Influence: 6.7]  [Reference Citation Analysis (0)]
29.  Dimitrov S, Benedict C, Heutling D, Westermann J, Born J, Lange T. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood. 2009;113:5134-5143.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 210]  [Cited by in F6Publishing: 228]  [Article Influence: 15.2]  [Reference Citation Analysis (0)]
30.  Smithers BM, Fahey PP, Corish T, Gotley DC, Falk GL, Smith GS, Kiroff GK, Clouston AD, Watson DI, Whiteman DC. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia. Med J Aust. 2010;193:572-577.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Tierney DK, Facione N, Padilla G, Dodd M. Response shift: a theoretical exploration of quality of life following hematopoietic cell transplantation. Cancer Nurs. 2007;30:125-138.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
32.  Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res. 2006;15:1533-1550.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 283]  [Cited by in F6Publishing: 293]  [Article Influence: 16.3]  [Reference Citation Analysis (0)]
33.  Rajandram RK, Jenewein J, McGrath C, Zwahlen RA. Coping processes relevant to posttraumatic growth: an evidence-based review. Support Care Cancer. 2011;19:583-589.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 71]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
34.  Urcuyo KR, Boyers AE, Carver CS, Antoni MH. Finding benefit in breast cancer: Relations with personality, coping, and concurrent well-being. Psychol Health. 2005;20:174-192.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 170]  [Cited by in F6Publishing: 101]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
35.  Lelorain S, Bonnaud-Antignac A, Florin A. Long term posttraumatic growth after breast cancer: prevalence, predictors and relationships with psychological health. J Clin Psychol Med Settings. 2010;17:14-22.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 142]  [Cited by in F6Publishing: 127]  [Article Influence: 9.1]  [Reference Citation Analysis (0)]
36.  NICR , 2008 Northern Ireland Cancer Registry, 2011 . Cancer in Ireland 1994-2004: a Comprehensive Report (NICR Publication) [Online] (Published 2008).  Available from: http:// http://www.ncri.ie/pubs/pubfiles/ALL_IRELAND_1994-2004_SUMMARY.pdf.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, Lagergren J. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther. 2007;26:683-691.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 98]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
38.  Bandura A Self-Efficacy: The Exercise of Control. New York: Freeman and Company 1977; 1-604.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Mystakidou K, Parpa E, Tsilika E, Gogou P, Panagiotou I, Galanos A, Kouvaris I, Gouliamos A. Self-efficacy, depression, and physical distress in males and females with cancer. Am J Hosp Palliat Care. 2010;27:518-525.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 23]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
40.  Hirai K, Suzuki Y, Tsuneto S, Ikenaga M, Hosaka T, Kashiwagi T. A structural model of the relationships among self-efficacy, psychological adjustment, and physical condition in Japanese advanced cancer patients. Psychooncology. 2002;11:221-229.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 59]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
41.  Cardenal V, Ortiz-Tallo M, Martín Frías I, Martínez Lozano J. Life stressors, emotional avoidance and breast cancer. Span J Psychol. 2008;11:522-530.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Myers LB. The importance of the repressive coping style: findings from 30 years of research. Anxiety Stress Coping. 2010;23:3-17.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 66]  [Cited by in F6Publishing: 57]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
43.  Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut. 2005;54 Suppl 1:i1-i5.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 160]  [Cited by in F6Publishing: 177]  [Article Influence: 9.3]  [Reference Citation Analysis (0)]
44.  Chandanos E, Lagergren J. The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer. 2009;45:3149-3155.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 41]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
45.  Nordenstedt H, El-Serag H. The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol. 2011;46:597-602.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 29]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
46.  Gleiberman L. Repressive/defensive coping, blood pressure, and cardiovascular rehabilitation. Curr Hypertens Rep. 2007;9:7-12.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 12]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]